Advertisement

Picture EBD Group Asia Bio Partnering Forum 2024 Singapore 650x100px

News > All

Total search results: 9965 | Ordered by Source (ascending)
1 2 3 ... 98 99 100  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
10x Genomics Inc.. (1/7/19). "Press Release: 10x Genomics Lands New Financing". Pleasanton, CA. 2019-01-07
10x Genomics Inc.. (10/5/20). "Press Release: 10x Genomics Advances into Emerging Field of In Situ Analysis with Two Acquisitions". Pleasanton, CA. 2020-10-05
10x Genomics Inc.. (12/10/18). "Press Release: 10x Genomics Acquires Spatial Transcriptomics". Pleasanton, CA. 2018-12-10
10x Genomics Inc.. (2/24/21). "Press Release: 10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event. Acquires Tetramer Shop, Reveals Details on Upcoming Products". Pleasanton, CA. 2021-02-24
10x Genomics Inc.. (4/26/18). "Press Release: 10x Genomics Completes $50 Million Series D Financing and $75M Debt Facility". Pleasanton, CA. 2018-04-26
2cureX AB. (1/28/21). "Press Release: 2cureX Appoints Kenneth Graabek Johansen, an Experienced Business and Financial Executive, as New CFO". Copenhagen. 2021-01-28
3B Pharmaceuticals GmbH. (11/20/18). "Press Release: Ipsen and 3BP Announce First Patient Dosed in Phase I/II Study for First-in-class Radionuclide (IPN01087)". Paris. 2018-11-20
3B Pharmaceuticals GmbH. (4/24/23). "Press Release: 3B Pharmaceuticals Enters into a Global Exclusive Licensing Agreement for its FAP-Targeting Peptide Technology". Berlin. 2023-04-24
3D Systems, Inc.. (2/23/22). "Press Release: 3D Systems to Expand Healthcare Applications Portfolio with Acquisition of Kumovis". Rock Hill, SC. 2022-02-23
3P Biopharmaceuticals S.L.. (7/23/19). "Press Release: 3P Biopharmaceuticals Welcomes Keensight Capital as Majority Shareholder". Paris. 2019-07-23
4basebio AG. (7/28/20). "Press Release: 4basebio Informs about Takeover Bid by Sparta AG". Heidelberg & Cambridge. 2020-07-28
4BIO Capital (4BIO Ventures Management Ltd.). (9/9/19). "Press Release: 4BIO Capital Raises $50 million in First Close of New Advanced Therapies Fund". London & Boston, MA. 2019-09-09
4D Lifetec AG. (10/18/23). "Press Release: 4D Lifetec Secures CHF 23.3 Mio in a Share and Investment Deal with Xlife Sciences Opening New Horizons in Using AI and Digital Health in Early Cancer Detection". Zürich & Cham. 2023-10-18
4D Lifetec AG. (7/11/22). "Press Release: 4D Lifetec Announces Successful First closing of CHF 1.9 Million Series B Financing to Launch Its Early Lung Cancer Detection Liquid Biopsy Assay 4D Lifetest Lung Dx in Europe". Cham. 2022-07-11
4D Molecular Therapeutics. (4/30/18). "Press Release: 4DMT and Roche Expand Ophthalmology Partnership to Develop and Commercialize Multiple AAV Gene Therapy Products". Emeryville, CA. 2018-04-30
4D Pharma plc. (10/8/19). "Press Release: 4D Pharma Collaborates with MSD to Develop Live Biotherapeutics for Vaccines". 2019-10-08
4SC AG. (10/10/17). "Press Release: Resminostat Demonstrates Potential to Significantly Alleviate Itching in CTCL Patients". Planegg-Martinsried. 2017-10-10
4SC AG. (10/18/23). "Press Release: 4SC Receives Orphan Drug Designation (ODD) for Resminostat (Kinselby) in CTCL in the European Union". Planegg-Martinsried. 2023-10-18
4SC AG. (10/26/17). "Press Release: 4SC Provides Q3 and 9M 2017 Update". Planegg-Martinsried. 2017-10-26
4SC AG. (10/7/19). "Press Release: 4SC AG Resolves to Issue New Shares, Santo and ATS Undertake to Subscribe / Buy the New Shares [Not for US, AU, CA, et al.]". Planegg-Martinsried. 2019-10-07
4SC AG. (11/12/19). "Press Release: 4SC AG Secures circa EUR 22.4 Million from a Capital Increase [Not for release in US, Australia, Canada, et al.]". Planegg-Martinsried. 2019-11-12
4SC AG. (11/25/20). "Press Release: 4SC AG Resolves to Issue New Shares with Expected Proceeds of approx. EUR 7.5 Million (ad hoc) [not for US, AU, CA, JP, ZA, et al.]". Planegg-Martinsried. 2020-11-25
4SC AG. (2/1/18). "Press Release: Positive DSMB Safety Review of 4SC’s Pivotal RESMAIN Study of Resminostat in CTCL". Planegg-Martinsried. 2018-02-01
4SC AG. (2/6/17). "Press Release: 4SC AG to Present at the 19th Annual BIO CEO & Investor Conference 2017". Planegg-Martinsried. 2017-02-06
4SC AG. (2/6/19). "Press Release: First Patient Enrolled in Phase II Study EMERGE of Domatinostat (4SC-202) in Gastrointestinal Cancer". Planegg-Martinsried. 2019-02-06
4SC AG. (3/20/19). "Press Release: 4SC AG Provides Results for Financial Year 2018 and Outlook". Planegg-Martinsried. 2019-03-20
4SC AG. (3/21/18). "Press Release: 4SC AG Announces Results for Financial Year 2017". Planegg-Martinsried. 2018-03-21
4SC AG. (3/27/18). "Press Release: Yakult Honsha Joins 4SC’s Pivotal RESMAIN Study of Resminostat in CTCL – 4SC Receives Milestone Payment". Planegg-Martinsried. 2018-03-27
4SC AG. (4/11/18). "Press Release: Yakult Honsha Recruits First Japanese Patient in 4SC’s Pivotal RESMAIN Study of Resminostat in CTCL". Planegg-Martinsried. 2018-04-11
4SC AG. (4/17/18). "Press Release: 4SC at AACR – Broadened Clinical Options for 4SC-202". Planegg-Martinsried. 2018-04-17
4SC AG. (4/19/18). "Press Release: Phase II Study of 4SC’s Resminostat in Biliary Tract Cancer in Japan Is Initiated". Planegg-Martinsried. 2018-04-19
4SC AG. (6/28/19). "Press Release: 4SC AG Secures EUR 11 Million from Capital Increase [Ad hoc, not for US, AU, CA, JP, ZA, et al.]". Planegg-Martinsried. 2019-06-28
4SC AG. (7/18/17). "Press Release: 4SC Licenses Kv1.3 Inhibitors to Maruho. Maruho to Receive Exclusive Worldwide License on 4SC’s Preclinical Inhibitors of the Kv1.3 Ion Channel". Planegg-Martinsried. 2017-07-18
4SC AG. (7/6/17). "Press Release: 4SC AG Secures EUR 41 Million from Successful Capital Increase [Not for US, AU, CA, JP or ZA]". Planegg-Martinsried. 2017-07-06
4SC AG. (8/1/17). "Press Release: 4SC AG Was Granted a Fundamental Composition of Matter Patent for 4SC-208 for the US". Planegg-Martinsried. 2017-08-01
4SC AG. (8/9/18). "Press Release: 4SC Provides Q2 and H1 2018 Update". Planegg-Martinsried. 2018-08-09
4SC AG. (9/11/20). "Press Release: 4SC and Maruho Discontinue Collaboration for Development of 4SC’s Kv1.3 Inhibitors". Planegg-Martinsried. 2020-09-11
4SC AG. (9/20/18). "Press Release: Domatinostat Plus Chemotherapy – Overcoming Drug Resistance". Planegg-Martinsried. 2018-09-20
4SC AG. (9/27/23). "Press Release: 4SC Receives Orphan Drug Designation (ODD) for Resminostat (Kinselby) in CTCL from the US FDA". Planegg-Martinsried. 2023-09-27
4Teen4 Pharmaceuticals GmbH. (12/5/19). "Press Release: Biotech Startup 4Teen4 Pharmaceuticals Closes EUR 7 Million Series A Financing". Hennigsdorf. 2019-12-05
77 Foods S.A.S. (d/b/a La Vie Foods). (1/19/22). "Press Release: The Start-up La Vie Raises €25M and Sets Out to Conquer the World with Its New Generation of Plant-based Meat". Paris. 2022-01-19
908 Devices, Inc.. (1/7/22). "Press Release: 908 Devices Announces GSK Purchases Fifth Rebel Cell Culture Media Analyzer". Boston, MA. 2022-01-07
908 Devices, Inc.. (6/22/21). "Press Release: 908 Devices Announces New Data Integrations with Key Industry Partners to Accelerate BioProcess Data Insights". Boston, MA. 2021-06-22
908 Devices, Inc.. (6/3/19). "Press Release: 908 Devices Broadens the ZipChip Platform, Brings New Capability to Biotherapeutics Researchers". Boston, MA. 2019-06-03
908 Devices, Inc.. (7/25/19). "Press Release: 908 Devices Poised to Modernize Upstream Bioprocess Analytics with a Grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)". Boston, MA. 2019-07-25
908 Devices, Inc.. (8/9/22). "Press Release: 908 Devices Acquires Trace Analytics, Enabling On-line Bioanalytics". Boston, MA. 2022-08-09
A-Mansia Biotech S.A.. (4/27/18). "Press Release: Belgian Microbiome Spin-off A-Mansia Announces €13m First Close of Series A Financing". Louvain-la-Neuve. 2018-04-27
Aadi Bioscience, Inc.. (5/8/17). "Press Release: Aadi Bioscience Closes $23 Million in Series A Funding". Pacific Palisades, CA. 2017-05-08
AATec Medical GmbH. (10/31/23). "Press Release: AATec Medical and Beurer Enter Development Collaboration for Inhaled Alpha-1 Antitrypsin". Munich. 2023-10-31
AATec Medical GmbH. (7/17/23). "Press Release: AATec Medical Announces Its Launch with EUR 2.7 Million in Seed Financing to Unlock the Therapeutic Potential of Alpha-1 Antitrypsin". Munich. 2023-07-17
AAVantgarde Bio S.r.l.. (6/6/23). "Press Release: AAVantgarde Closes €61 Million Series A Financing to Advance Two Therapeutic Programs into the Clinic". Milan. 2023-06-06
AAVantgarde Bio S.r.l.. (9/8/22). "Press Release: AAVantgarde Bio Appoints Dr. Natalia Misciattelli as Chief Executive Officer". Milan. 2022-09-08
AaviGen GmbH. (7/26/23). "Press Release: AaviGen Raises 17 Million € in Second Financing Round to Advance Precision Gene Therapies for Heart Failure towards the Clinical Stage". Heidelberg. 2023-07-26
AAX Biotech AB. (11/28/23). "Press Release: AAX Biotech Forms Strategic Collaboration with Oblique Therapeutics for Therapeutic Antibody Development". 2023-11-28
AAX Biotech AB. (9/28/23). "Press Release: AAX Biotech Welcomes New CEO to Drive Advancements in Next-generation Antibody Therapeutics". 2023-09-28
AB Science S.A.. (2/28/22). "Press Release: Financing of 8.5 Million Dollars through the Issuance of Convertible Bonds with Attached Warrants (with a Conversion Price of EUR 14.0) [Not for US, CA, AU or JP]". Paris. 2022-02-28
AB Science S.A.. (3/27/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris. 2017-03-27
AB Science S.A.. (3/31/17). "Press Release: AB Science Announces the Success of a Private Placement [Not for US, CA or JP]". Paris. 2017-03-31
AB Science S.A.. (5/12/17). "Press Release: AB Science Announces that ANSM Requested the Temporary Suspension of Clinical Studies Conducted in France Following Deviations from Good Clinical Practice (GCP) Standards". Paris. 2017-05-12
AB Sciex (d/b/a Sciex). (11/09/17). "Press Release: New Method for the Detection of Fipronil Insecticide and Its Associated Metabolites in Eggs and Poultry Launched by Sciex". Warrington. 2017-11-09
AB Sciex (d/b/a Sciex). (11/1/21). "Press Release: Sciex and Evosep Will Collaborate to Provide Robust, High-throughput Proteomics Workflows". 2021-11-01
AB Sciex (d/b/a Sciex). (12/18/17). "Press Release: Sciex and NofaLab Collaboration Delivers Robust and Sensitive Method for Detecting Multiple Pesticides in a Single Run". Warrington, UK. 2017-12-18
AB Sciex (d/b/a Sciex). (3/22/17). "Press Release: Sciex Presents Novel QTOF Mass Spectrometry System for Simpler and Faster Biotherapeutics Characterisation". Darmstadt. 2017-03-22
AB Sciex (d/b/a Sciex). (4/10/18). "Press Release: Sciex Launches the Citrine Triple Quad MS/MS Systems in Europe, Bringing Maximal Speed and Sensitivity to Clinical Diagnostics Testing". Darmstadt. 2018-04-10
AB Sciex (d/b/a Sciex). (6/1/17). "Press Release: Sciex Announces Innovative Solutions for Customer Success Across Markets at ASMS 2017". Framingham, MA. 2017-06-01
AB Sciex (d/b/a Sciex). (6/1/17). "Press Release: Sciex Launches Its Unrivalled Swath Data Independent Acquisition Technology for Comprehensive Analysis of Food, Forensic and Environmental Samples". Framingham, MA. 2017-06-01
AB Sciex (d/b/a Sciex). (7/27/17). "Press Release: Sciex Equipment Is Now Available Through a Wide Range of Flexible Financing Packages via Evosciences". Warrington. 2017-07-27
AB Sciex (d/b/a Sciex). (9/13/17). "Press Release: Meet Sciex and Learn about Industrialized Biomarker Research Using SWATH Acquisition at HUPO 2017". Framingham, MA. 2017-09-13
AB Sciex (d/b/a Sciex). (9/15/17). "Press Release: Sciex Announces the Appointment of Inese Lowenstein as President. Former President Jean-Paul Mangeolle to Retire". Framingham, MA. 2017-09-15
AB Sciex (d/b/a Sciex). (9/23/19). "Press Release: Sciex Medical Devices Set to Address the Challenges faced by Brazil’s Clinical Diagnostics Laboratories". São Paulo. 2019-09-23
AB Sciex (d/b/a Sciex). (9/5/19). "Press Release: Sciex Launches Partner Portal to Support Customer Needs Worldwide and Extend Network". Framingham, MA. 2019-09-05
AB Sciex (d/b/a Sciex). (9/6/17). "Press Release: Sciex PA 800 Plus Continues to Deliver Quality Results for Ultimate Confidence in Biologics Characterization Data". Framingham, MA. 2017-09-06
AB Sciex (d/b/a Sciex). (9/8/17). "Press Release: Sciex Launches the Topaz LC-MS/MS System for Clinical Diagnostics in Europe". Warrington, UK. 2017-09-08
ABAC Therapeutics. (2/15/18). "Press Release: ABAC Therapeutics Announces €16 Million Series A to Develop Therapeutic Solutions to Fight Antibiotic-resistant Bacteria". Barcelona. 2018-02-15
Abalos Therapeutics GmbH. (10/14/21). "Press Release: Abalos Therapeutics Completes Series A Extension Bringing Total Raised to EUR 43 Million". Düsseldorf. 2021-10-14
Abalos Therapeutics GmbH. (10/15/19). "Press Release: Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer". Essen. 2019-10-15
AbbVie Inc.. (1/25/19). "Press Release: AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results". North Chicago, IL. 2019-01-25
AbbVie Inc.. (10/20/22). "Press Release: AbbVie Acquires DJS Antibodies, Further Strengthening Immunology Pipeline". North Chicago, IL. 2022-10-20
AbbVie Inc.. (3/1/22). "Press Release: AbbVie Acquires Syndesi Therapeutics, Strengthening Neuroscience Portfolio". North Chicago, IL. 2022-03-01
AbbVie Inc.. (6/25/19). "Press Release: AbbVie to Acquire Allergan in Transformative Move for Both Companies". 2019-06-25
Abcam plc. (10/23/20). "Press Release: Abcam Announces Exercise of Over-allotment Option [not for any jurisdiction where a violation of relevant laws]". London. 2020-10-23
Abcam plc. (10/23/20). "Press Release: Abcam Announces Launch of Offering and Application to List on the Nasdaq Global Market". London. 2020-10-23
Abcam plc. (10/23/20). "Press Release: Abcam Announces Pricing of Offering on Nasdaq". London. 2020-10-23
Abcam plc. (4/26/18). "Press Release: Abcam and Shuwen Biotech Sign Strategic MoU to Establish Global Alliance for Companion Diagnostic (CDx) Kit Development". Cambridge & Deqing. 2018-04-26
Abcam plc. (5/18/17). "Press Release: Abcam Makes Final Performance-Based AxioMx Milestone Payment". Cambridge. 2017-05-18
Abcam plc. (6/23/23). "Press Release: Abcam Announces Review of Strategic Alternatives". Cambridge & Waltham, MA. 2023-06-23
Abcam plc. (7/2/18). "Press Release: Abcam Merck Collaboration Produces New PD-L1 Antibody for Immuno-Oncology Research". Cambridge. 2018-07-02
Abcam plc. (8/2/21). "Press Release: Abcam to Acquire BioVision for $340 Million". Cambridge. 2021-08-02
AbCellera Biologics, Inc.. (11/29/18). "Press Release: AbCellera Collaborates with Autolus on Antibody Discovery Project". Vancouver, BC. 2018-11-29
AbCellera Biologics, Inc.. (2/14/19). "Press Release: AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma". Vancouver, BC. 2019-02-14
AbCellera Biologics, Inc.. (5/30/18). "Press Release: AbCellera and Harbour Antibodies Announce Technology Co-Offering Agreement for Next-Generation Fully-Human Antibody Discovery". Vancouver, BC, Rotterdam & Cambridge, MA. 2018-05-30
AbCellera Biologics, Inc.. (9/12/17). "Press Release: AbCellera Launches Antibody Discovery Collaboration with GSK". Vancouver, BC. 2017-09-12
Abeona Therapeutics Inc.. (4/2/18). "Press Release: Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer". New York, NY & Cleveland, OH. 2018-04-02
Aber Instruments. (2/1/21). "Press Release: Aber Instruments Acquires BugLab to Consolidate its World-leading Biomass Monitoring Portfolio". Alexandria, VA. 2021-02-01
Aber Instruments. (3/22/21). "Press Release: Aber Introduces Futura neotf On-line Single-use Biomass Sensor". Aberystwyth. 2021-03-22
Abera Bioscience AB. (3/29/22). "Press Release: Abera Bioscience Signs Agreement with NorthX Biologics for GMP Manufacturing". 2022-03-29
Ability Pharmaceuticals S.L.. (9/18/17). "Press Release: Ability Pharmaceuticals Announces EMA-Orphan Drug Designation for ABTL0812 in Pancreatic Cancer". Barcelona. 2017-09-18
Abingdon Health Ltd.. (10/16/17). "Press Release: Abingdon Health and Skannex Sign a Co-marketing Agreement". 2017-10-16
Abingworth LLP. (10/30/23). "Press Release: Abingworth Raises $356 Million for New Clinical Co-Development Co-Investment Fund (CCD-CIF)". London & New York, NY. 2023-10-30
Abingworth LLP. (2/3/21). "Press Release: Abingworth Raises $465m for New Life Sciences Fund Abingworth Bioventures 8". London. 2021-02-03
1 2 3 ... 98 99 100  next pagenext page



Advertisement

Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x300px

» top